Funding for this research was provided by:
University of New South Wales (Scientia PhD Scholarship)
Medical Research Council (MR/P014550/1)
National Health and Medical Research Council (APP1174120, APP1149987)
Received: 17 January 2021
Accepted: 7 April 2021
First Online: 19 May 2021
: UK Biobank has obtained Research Tissue Bank approval from its governing Research Ethics Committee, as recommended by the National Research Ethics Service. This research has been conducted using the UK Biobank Resource (application No. 2495). Permission to use the UK Biobank Resource was approved by the access subcommittee of the UK Biobank Board. Written informed consent was obtained for all participants electronically.
: Not applicable.
: All authors have completed the Unified Competing Interest form and declare: no support from any organisation for the submitted work; MW does consultancy for Amgen, Freeline and Kirin outside the submitted work; no other relationships or activities that could appear to have influenced the submitted work.